Thank you for visiting this space dedicated to celebrating, remembering, and honoring our dad. Here we share our favorite stories and memories.
The turn of the century marked a new beginning for Tom. Not only did he assist with the "Y2K" computer crisis, he rekindled his relationship with his twin daughters, Theresa and Lillian. It was around this time too, that he was diagnosed with Parkinson's Disease. Throughout the first decade of the century, he managed his disease on his own. In 2011, his daughters started to assist with the management of the disease and eventually moved him to Marina Del Rey, CA where he would be closer to them and in a more favorable environment for disease management. Once settled in CA, Tom was an active member of the community in which he lived. He enjoyed going to the gym for light workouts, using the pool and jacuzzi, walking the neighborhood, going for coffee and to the farmers market. He was always chatting up the residents of his home as well as the staff. He liked to host a Bible study group and participate in the Resident Council Meetings. The last few years have been very enjoyable ones for Tom.
This page is also a place to support The Michael J. Fox Foundation's mission to end Parkinson's. Every person and family touched by this disease knows the urgency for a cure. But we also can take heart in the tremendous progress that has unfolded since the Foundation opened its doors. Those living with Parkinson's have every reason to look to the future with hope.
The Foundation believes we are closer than ever to breakthrough treatments. We want to do everything we can to help. Please consider joining us in the cause - in tribute to our dad and in honor of the five million living with Parkinson's worldwide.
The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease and to ensuring the development of improved therapies for those living with Parkinson's today. The Foundation is the world's largest nonprofit funder of Parkinson's research, with more than $800 million in high-impact research funded to date.
Get Involved